The Business Times

talkmed group

Companies & Markets

TalkMed to delist from SGX on Sep 15

TalkMed expects the last day for its shares to be traded to be on or around Aug 8.
Companies & Markets

TalkMed shareholders approve Tamarind Health’s privatisation offer

From left: Adrienne Teh, managing director; Francis Woo, chief corporate officer and managing director (Singapore); chief executive Tan Chong Lee; and investment principal Timothy Wee.
Companies & Markets

65 Equity Partners’ two Singapore funds focus on driving growth in companies regardless of former listing status

The move by 65 Equity Partners is happening against the backdrop of Singapore’s amped-up efforts to revive the ailing local equities market. In 2024, delistings from the Singapore Exchange outpaced new entrants to the bourse.
Columns
HOCK LOCK SIEW

Fund manager 65 Equity Partners’ role in TalkMed privatisation offer is at odds with its core

The offer price is 20 per cent higher than the counter's last traded price of S$0.38 on Apr 5.
Companies & Markets

TalkMed receives S$0.456 per share in privatisation offer via scheme of arrangement

TalkMed will update shareholders in due course when it becomes aware of any material developments.
Consumer & Healthcare

Discussions on stake sale still ongoing, says TalkMed

TalkMed Group faces growing competition for medical tourists in South-east Asia, due to a strong Singapore dollar.
Consumer & Healthcare

TalkMed H2 net profit dips 2.8% to S$17.9 million despite revenue increase

TalkMed Group saw its oncology services revenue rise 19.9 per cent to S$37.5 million
Companies & Markets

TalkMed Group posts 17.7% rise in H1 net profit on improved patient numbers

Earnings per share for H2 2022 stood at 1.39 Singapore cents per share, up from 1.08 Singapore cents in 2021.
Companies & Markets

TalkMed Group posts 29% rise in H2 net profit to S$18.4 million on more patient visits

Talkmed noted that the lifting of Covid-19 travel restrictions in April 2022, meant that the number of patient visits increased compared to the same corresponding period last year.
Companies & Markets

TalkMed Group H1 net profit rises 12.2% on higher revenue

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More